Identification of Akt pathway inhibitors using redistribution screening on the FLIPR and the IN Cell 3000 analyzer.

Autor: Lundholt BK; BioImage A/S, Copenhagen, Denmark., Linde V, Loechel F, Pedersen HC, Møller S, Praestegaard M, Mikkelsen I, Scudder K, Bjørn SP, Heide M, Arkhammar PO, Terry R, Nielsen SJ
Jazyk: angličtina
Zdroj: Journal of biomolecular screening [J Biomol Screen] 2005 Feb; Vol. 10 (1), pp. 20-9.
DOI: 10.1177/1087057104269989
Abstrakt: The PI3-kinase/Akt pathway is an important cell survival pathway that is deregulated in the majority of human cancers. Despite the apparent druggability of several kinases in the pathway, no specific catalytic inhibitors have been reported in the literature. The authors describe the development of a fluorometric imaging plate reader (FLIPR)-based Akt1 translocation assay to discover inhibitors of Akt1 activation. Screening of a diverse chemical library of 45,000 compounds resulted in identification of several classes of Akt1 translocation inhibitors. Using a combination of classical in vitro assays and translocation assays directed at different steps of the Akt pathway, the mechanisms of action of 2 selected chemical classes were further defined. Protein translocation assays emerge as powerful tools for hit identification and characterization.
Databáze: MEDLINE